In support of the hypothesis that dystrophin‐mutated iPSC‐CMs from the mutant male and the heterozygous female carrier exhibit key features of DMD, mutated cardiomyocytes displayed molecular, genetic and electrophysiological abnormalities, including arrhythmias. The gene discussed is DMD; the disease is cardiac arrhythmia.